It’s been a little more than a year since China’s FDA (CFDA) announced sweeping policy changes intended to streamline the review of innovative new drugs and rid their system of subpar applicants blocking the progress of true candidates…
Update on CFDA’s Fast-Track Approval: 7 MNC Products Move to Data Inspection Stage

January 10, 2017 | Category: Blog | Tags: CFDA Policy Changes, China CMO, China Fill Finish, Fast Track Approval